Khan Eshan, Mishra Subodh K, Kumar Amit
Centre for Biosciences and Biomedical Engineering, Indian Institute of Technology, Indore 452017, Madhya Pradesh. India.
Protein Pept Lett. 2017;24(4):331-339. doi: 10.2174/0929866524666170206123150.
Protein misfolding and aggregation is a key attribute of different neurodegenerative diseases. Misfolded and aggregated proteins are intrinsically disordered and rule out structure based drug design. The comprehensive characterization of misfolded proteins and associated aggregation pathway is prerequisite to develop therapeutics for neurodegenerative diseases caused due to the protein aggregation. Visible protein aggregates used to be the final stage during aggregation mechanism. The structural analysis of intermediate steps in such protein aggregates will help us to discern the conformational role and subsequently involved pathways. The structural analysis of protein aggregation using various biophysical methods may aid for improved therapeutics for protein misfolding and aggregation related neurodegenerative diseases. In this mini review, we have summarized different spectroscopic methods such as fluorescence spectroscopy, circular dichroism (CD), nuclear magnetic resonance (NMR) spectroscopy, Fourier transform infrared spectroscopy (FTIR), and Raman spectroscopy for structural analysis of protein aggregation. We believe that the understanding of invisible intermediate of misfolded proteins and the key steps involved during protein aggregation mechanisms may advance the therapeutic approaches for targeting neurological diseases that are caused due to misfolded proteins.
蛋白质错误折叠和聚集是不同神经退行性疾病的关键特征。错误折叠和聚集的蛋白质本质上是无序的,排除了基于结构的药物设计。对错误折叠蛋白质及其相关聚集途径进行全面表征是开发针对由蛋白质聚集引起的神经退行性疾病的治疗方法的先决条件。可见的蛋白质聚集体曾经是聚集机制的最后阶段。对此类蛋白质聚集体中间步骤的结构分析将有助于我们识别构象作用以及随后涉及的途径。使用各种生物物理方法对蛋白质聚集进行结构分析可能有助于改进针对与蛋白质错误折叠和聚集相关的神经退行性疾病的治疗方法。在这篇小型综述中,我们总结了不同的光谱方法,如荧光光谱、圆二色性(CD)、核磁共振(NMR)光谱、傅里叶变换红外光谱(FTIR)和拉曼光谱,用于蛋白质聚集的结构分析。我们相信,对错误折叠蛋白质的不可见中间体以及蛋白质聚集机制中涉及的关键步骤的理解可能会推进针对由错误折叠蛋白质引起的神经系统疾病的治疗方法。